Deep Tech Startups

Augmental makes the MouthPad^, a hands-free touchpad worn on the roof of the mouth that converts head and tongue gestures into cursor control and clicks for phones, computers, and tablets via Bluetooth. It is used for accessible, hands-free human-computer interaction, with early adopters including individuals with diverse physical abilities in the United States.

1 investor

Augmented Hearing develops Sharpi, an AI speech-enhancement technology using a deep neural network to separate voice from background noise on incoming and outgoing audio. It serves emergency 112 call centers, contact centers, and hardware makers embedding the technology in headsets and hearing devices, offered via app, SDK, SIP Bridge, or on-prem box.

1 investor

Augmenteum develops liquid crystal-based active optics that perform real-time aberration correction, jitter reduction, and field-of-view enhancement for smaller, lighter optical systems. Its technology targets applications including AR/VR wearables, cameras and sensors, microscopy, drones, industrial robotics, defense, and ophthalmic imaging.

1 investor

Augmind builds fully-interactive, real-time mixed reality experiences using proprietary AI-based shader technology to composite life-like 3D visuals that blend with a user's environment. Its platform targets uses such as retail shopping experiences, real estate/interior design walkthroughs, and gaming, delivered on mobile and web devices running Google ARCore or Apple ARKit.

1 investor

AugurSim builds pretrained AI physics simulators that adapt to a customer's geometry and physics domain, delivering sub-minute inference for pressure, velocity, temperature, and stress fields across meshes of 100M+ nodes. It targets engineering and CAE teams in aerospace, automotive crash, defense, and industrial design, integrating with existing simulation pipelines and standard formats like STL and VTK.

1 investor

Aukera Therapeutics is a preclinical-stage biotech company, spun out of the University of Basel's Biozentrum, developing the first RAPTOR inhibitors to treat mTORC1-related diseases. It pairs mTOR pathway expertise with an AI-driven drug discovery engine aimed at complex, hard-to-drug targets.

1 investor

Auni Therapeutics develops a next-generation immunotherapy platform for food allergies, initially targeting peanut allergy with the aim of expanding across multiple allergens. The company focuses on translating immunology research into durable therapeutic assets for patients with severe food allergies.

1 investor

AuraSense builds physics-informed AI that captures and analyzes human movement — combining pose, audio, and facial sentiment — using biomechanical constraints and inverse kinematics to produce real-time insights. Its platform serves applications across gaming, sports, and clinical research.

1 investor

Aurealis Therapeutics is a Swiss-Finnish clinical-stage company developing multi-target bacterial gene therapies based on genetically engineered Lactococcus cremoris, using a modular platform that produces multiple human therapeutic proteins directly in diseased tissue. Its therapies target chronic wounds, cancer, and inflammatory diseases, with a lead product for diabetic foot ulcers.

1 investor

Auricle develops a neurostimulation implant designed to restore hearing for patients who do not benefit from hearing aids or existing solutions.

1 investor

Aurigin provides real-time deepfake detection for voice biometric systems and communication platforms, identifying synthetic, cloned, and AI-generated audio with 98%+ accuracy. The solution integrates via API or SDK to protect authentication systems and contact centers against voice spoofing attacks across 80+ languages.

1 investor

Auron Solutions develops software-defined technology to detect, classify, and intercept hostile drone signals while protecting military and critical infrastructure environments. The company provides non-kinetic electronic warfare capabilities designed for modern autonomous drone threats.

1 investor

Aurora develops advanced air vehicles and enabling technologies, including aircraft configurations, autonomous systems, and propulsion, for government and commercial customers. The company designs and builds aircraft from concept through manufacturing in the aerospace industry.

1 investor

Aurora develops a platform for personalized gene editing to treat rare genetic diseases at scale. The company targets patients with rare disease variants by systematizing and scaling gene editing treatments to address genetic mutations that lack existing therapeutic options.

1 investor

Aurora develops plug-and-play propulsion and end-of-life deorbiting systems, including ARM thrusters and Plasma Brake tethers, for CubeSats and SmallSats up to 300kg. It targets satellite integrators, operators, and defense customers with ITAR-free, zero-debris hardware built on a European supply chain.

1 investor

Aurorin builds a modern CAD platform designed to accelerate engineering iteration by reducing software latency and integrating AI-native workflows. The company targets engineers and product teams who need faster design feedback cycles across industries including aerospace, robotics, and medical devices.

1 investor

The Australian Technologies Competition (ATC) is a technology competition and awards program that has run since 2010, connecting entrants with investors, mentors, and industry leaders. It has built an alumni network of more than 600 semi-finalists and focuses on innovation with global impact.

1 investor

AuthenX designs optoelectronic components and optical transceiver modules based on III-V and silicon photonics technology for 5G, satellite communications, fiber networks, and data center applications.

1 investor

Autolab is an autoresearch platform that uses autonomous AI agents to run the machine learning research loop, proposing experiments, writing code, training and evaluating models, and iterating against a user-defined eval and goal. It runs thousands of experiments in parallel on a customer's own GPUs or cloud account, serving ML teams working on pre-training, fine-tuning, post-training, and inference optimization.

1 investor

Autobrains develops Agentic AI vision software for advanced driver assistance systems (ADAS) and autonomous driving, scaling from L2++ to L4 for automakers building robotaxis and mass-market vehicles. Its software runs on minimal compute and few cameras, is SoC and sensor agnostic, and complies with GSR regulations and NCAP safety standards.

1 investor

AutoFlight develops electric vertical takeoff and landing (eVTOL) aircraft and works with aviation regulators including Europe's EASA, China's CAAC, and the UAE's GCAA on safety certification.

1 investor

Autolab is an autoresearch platform for AI model training that uses autonomous AI agents to plan, code, run, and score machine learning experiments in parallel across a customer's own compute, iterating until a defined goal and eval metric are met. It serves ML teams working on pre-training, fine-tuning, post-training, and inference optimization, running on the customer's cluster or cloud account so code, data, and weights stay within their network.

1 investor

Automatika develops software infrastructure for intelligent robots and physical agents using computer vision, control theory, and machine learning. The company was founded as a spin-off from Inria, France's national research institute for computer science and AI.

1 investor

Automera develops a drug-discovery platform that uses computational chemistry, AI, and quantum molecular dynamics to design chimeric small molecules with dual-binding capabilities targeting autophagy-driven degradation. Its approach addresses disease targets in areas such as cancer, inflammation, and the central nervous system.

1 investor